| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/QAI.0B013E31820B07AB |
| P8608 | Fatcat ID | release_l6i5lklmsjbaznwbovikm66d7y |
| P932 | PMC publication ID | 3383328 |
| P698 | PubMed publication ID | 21239993 |
| P50 | author | Madhukar Pai | Q30332033 |
| Adithya Cattamanchi | Q91293754 | ||
| Karen R Steingart | Q96216065 | ||
| Philip C Hopewell | Q114341901 | ||
| P2093 | author name string | Laurence Huang | |
| Rachel Smith | |||
| John Z Metcalfe | |||
| Barbara J Marston | |||
| Courtney Coleman | |||
| Anand Date | |||
| P2860 | cites work | Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update | Q22241138 |
| Treatment of latent tuberculosis infection in HIV infected persons | Q24241052 | ||
| Conducting systematic reviews of diagnostic studies: didactic guidelines | Q24797459 | ||
| The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews | Q24801517 | ||
| Clinical practice. Latent tuberculosis infection | Q28216676 | ||
| Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group | Q73005996 | ||
| A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations | Q74545500 | ||
| Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients | Q79667613 | ||
| Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS) | Q79775663 | ||
| Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country | Q82587840 | ||
| Evaluation of immune responses in HIV infected patients with pleural tuberculosis by the QuantiFERON TB-Gold interferon-gamma assay | Q33325633 | ||
| The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis | Q33401266 | ||
| Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals | Q33408006 | ||
| High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area | Q33454961 | ||
| Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals | Q33455753 | ||
| Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review | Q33521202 | ||
| Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection | Q33543398 | ||
| How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? | Q33753176 | ||
| Isoniazid for preventing tuberculosis in non-HIV infected persons | Q33900621 | ||
| Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts. | Q34512206 | ||
| New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis | Q34527311 | ||
| Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort | Q34717889 | ||
| Exploring sources of heterogeneity in systematic reviews of diagnostic tests | Q34733068 | ||
| Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test | Q34872252 | ||
| Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals | Q35855200 | ||
| Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. | Q35965052 | ||
| Systematic reviews of diagnostic test accuracy | Q37346962 | ||
| High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico | Q37347597 | ||
| T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings | Q37456015 | ||
| Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. | Q37767584 | ||
| Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis | Q37804607 | ||
| Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection | Q38874151 | ||
| Controlled chemoprophylaxis trials in tuberculosis. A general review | Q39002300 | ||
| Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals. | Q39818804 | ||
| Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy | Q44256028 | ||
| Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. | Q45375285 | ||
| Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease | Q45401374 | ||
| Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers | Q46109020 | ||
| High level of discordant IGRA results in HIV-infected adults and children. | Q46231572 | ||
| A comparative study of two different methods for the detection of latent tuberculosis in HIV-positive individuals in Chile. | Q47659031 | ||
| Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? | Q51098184 | ||
| Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. | Q51797725 | ||
| Reliability of tuberculin skin test measurement. | Q52892588 | ||
| Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. | Q55043482 | ||
| Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis | Q56401830 | ||
| Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count | Q56405363 | ||
| QuantiFERON-TB GOLD ELISA assay for the detection ofMycobacterium tuberculosis-specific antigens in blood specimens of HIV-positive patients in a high-burden country | Q57209245 | ||
| Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients | Q58877097 | ||
| Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA) | Q71833584 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| systematic review | Q1504425 | ||
| tuberculosis | Q12204 | ||
| latent tuberculosis | Q4254929 | ||
| P304 | page(s) | 230-238 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis | |
| P478 | volume | 56 |
| Q28547313 | A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study |
| Q54258866 | A multicentre verification study of the QuantiFERON®-TB Gold Plus assay. |
| Q50956466 | A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays. |
| Q91907928 | A systematic review of biomarkers to detect active tuberculosis |
| Q38149466 | A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications |
| Q26750756 | Accuracy of the Bronchoalveolar Lavage Enzyme-Linked Immunospot Assay for the Diagnosis of Pulmonary Tuberculosis: A Meta-analysis |
| Q33759993 | Added value of QuantiFERON TB-gold in-tube for detecting latent tuberculosis infection among persons living with HIV/AIDS. |
| Q36627619 | Advances in the Diagnosis, Treatment and Control of HIV Associated Tuberculosis |
| Q90568104 | Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings |
| Q98630215 | Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results |
| Q84357905 | Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation |
| Q36684265 | Application and interpretation of an interferon-gamma release assay: Results of an audit in a Canadian centre |
| Q33777072 | Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting? |
| Q33699313 | Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits. |
| Q38111807 | Biomarkers of tuberculosis: a research roadmap |
| Q90371904 | Borderline QuantiFERON results and the distinction between specific responses and test variability |
| Q34321694 | Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients. |
| Q35125891 | C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings |
| Q91097226 | Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study |
| Q47284740 | Comparison of Interferon-γ Release Assays and the Tuberculin Skin Test for Diagnosis of Tuberculosis in Human Immunodeficiency Virus: A Systematic Review |
| Q35800557 | Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study |
| Q35598203 | Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy. |
| Q33938067 | Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults |
| Q35110105 | Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube |
| Q34360363 | Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test |
| Q28729742 | Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting |
| Q104459146 | Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV |
| Q28393022 | Diagnosis and management of miliary tuberculosis: current state and future perspectives |
| Q34926355 | Diagnostic performance of interferon-gamma releasing assay in HIV-infected patients in China |
| Q40351712 | Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting |
| Q61908213 | Effective Tuberculosis and Hepatitis Screening Prior to Anti-TNF-α Therapy: Are We There Yet? |
| Q57093725 | Evaluating latent tuberculosis infection diagnostics using latent class analysis |
| Q47340142 | Evaluation of interferon-gamma release assays for the diagnosis of tuberculosis: an updated meta-analysis |
| Q47119702 | Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy |
| Q30275004 | Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis |
| Q40118774 | Frequency of indeterminate results from an interferon-gamma release assay among HIV-infected individuals. |
| Q37544916 | Gamma interferon release assays for detection of Mycobacterium tuberculosis infection |
| Q40600140 | IFN-γ Release Assay Result Is Associated with Disease Site and Death in Active Tuberculosis |
| Q38069419 | IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults |
| Q50100072 | IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results? |
| Q37988577 | IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions |
| Q27002561 | Immune response to mycobacterial infection: lessons from flow cytometry |
| Q37949170 | Immunodiagnosis of tuberculosis: state of the art. |
| Q38661918 | Immunological recovery in tuberculosis/HIV co-infected patients on antiretroviral therapy: implication for tuberculosis preventive therapy |
| Q34456369 | Impact of co-infections and BCG immunisation on immune responses among household contacts of tuberculosis patients in a Ugandan cohort. |
| Q39433439 | Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.(®)TB and QFT-GIT). |
| Q41089864 | Implementation of latent tuberculosis screening in HIV care centres: evaluation in a low tuberculosis incidence setting |
| Q37887544 | Improving the diagnosis of tuberculosis: From QuantiFERON to new techniques to diagnose tuberculosis infections |
| Q33824247 | In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection. |
| Q36353973 | In vitro immunomodulation of a whole blood IFN-γ release assay enhances T cell responses in subjects with latent tuberculosis infection |
| Q29247882 | Incidence and correlates of tuberculosis IGRA conversion among HIV-infected postpartum women |
| Q36120455 | Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design |
| Q34575195 | Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country |
| Q36599355 | Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms. |
| Q35978098 | Interferon-Gamma Release Assays for the Diagnosis of Tuberculosis: A Systematic Review and Meta-analysis |
| Q36637982 | Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence |
| Q38231682 | Interferon-gamma release assays and the diagnosis of tuberculosis: have they found their place? |
| Q43196415 | Interferon-gamma release assays for screening of health care workers in low tuberculosis incidence settings: dynamic patterns and interpretational challenges. |
| Q21090976 | Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: a systematic review and meta-analysis |
| Q38168914 | Interferon-gamma release assays for tuberculosis: current and future applications |
| Q59330116 | Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study |
| Q22242874 | Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis |
| Q28731541 | Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis |
| Q36349908 | Latent TB infection and pulmonary TB disease among patients with diabetes mellitus in Bandung, Indonesia |
| Q58438806 | Latent Tuberculosis Infection Screening Acceptability among Migrant Farmworkers |
| Q34257658 | Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study |
| Q39402245 | Latent tuberculosis among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan: TSPOT.TB versus tuberculin skin test |
| Q48462652 | Latent tuberculosis infection as a target for tuberculosis control |
| Q54207984 | Latent tuberculosis infection: An overview. |
| Q35199257 | Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy |
| Q46416408 | Microfluidic compartments with sensing microbeads for dynamic monitoring of cytokine and exosome release from single cells |
| Q40296865 | Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California |
| Q41391483 | Mycobacterium tuberculosis-specific CD4 T cells are the principal source of IFN-γ in QuantiFERON assays in healthy persons |
| Q34523794 | Negative effect of smoking on the performance of the QuantiFERON TB gold in tube test |
| Q35140420 | Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark |
| Q53641549 | Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. |
| Q37980410 | Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis. |
| Q27004505 | Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics |
| Q35029529 | Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia |
| Q35118980 | Predictive value of interferon-gamma release assays for postpartum active tuberculosis in HIV-1-infected women |
| Q27000984 | Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis |
| Q61797265 | Predictors of discordant latent tuberculosis infection test results amongst South African health care workers |
| Q34309664 | Prevalence of latent tuberculosis infection and associated risk factors among 3,374 healthcare students in Italy. |
| Q51859231 | Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. |
| Q90428594 | Progress in interferon-gamma release assay development and applications: an unfolding story of translational research |
| Q36118644 | Promise versus reality: optimism bias in package inserts for tuberculosis diagnostics |
| Q41757618 | QuantiFERON–TB Gold In-Tube test performance in Denmark |
| Q38797602 | Reactivation tuberculosis: role of surveillance |
| Q38609947 | Recommendations for the diagnosis of pediatric tuberculosis |
| Q37940571 | Redefining latent tuberculosis |
| Q24201325 | Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB |
| Q41657767 | Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. |
| Q64913653 | Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis. |
| Q33869437 | Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa |
| Q35566421 | Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB Test |
| Q34550583 | Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. |
| Q51873726 | Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids. |
| Q38411930 | Screening and vaccinations in patients requiring systemic immunosuppression: an update for dermatologists |
| Q38265740 | Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis |
| Q64946439 | Serpiginoid choroiditis associated with presumed ocular tuberculosis. |
| Q42773052 | Should interferon gamma release assays become the standard method for screening patients for Mycobacterium tuberculosis infections in the United States? |
| Q37899891 | T-SPOT.TB assay usage in adults and children |
| Q84775916 | Tests for prediction of active tuberculosis |
| Q36131061 | The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis |
| Q36273950 | The top-cited systematic reviews/meta-analyses in tuberculosis research: A PRISMA-compliant systematic literature review and bibliometric analysis |
| Q40683319 | Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study |
| Q41646801 | Tuberculin skin test and QuantiFERON-TB Gold In-tube Test for latent tuberculosis in Thai HIV-infected adults |
| Q38002002 | Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities |
| Q40208853 | Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay. |
| Q90536847 | Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting |
| Q38102726 | Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective. |
| Q28073158 | Updates on the risk factors for latent tuberculosis reactivation and their managements |
| Q40931904 | Utility of QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent TB in HIV-Positive Patients in a Medium-TB Burden Country. |
Search more.